$VRSN Balance Sheet | Understand Stock

$VRSN

$301.16 -$7.56 (2.45%) Live

$VRSN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q3 FY2026 As of Sep 30, 2026	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Marketable securities
Other current assets
Other Assets, Current
Total current assets
Property and equipment, net
Goodwill
Intangible Asset, Excluding Goodwill, Indefinite-Lived
Deferred Income Tax Assets, Net
Deposits to acquire Intangible Assets
Other long-term assets
Total long-term assets
Total assets
Current liabilities:
Accounts payable and accrued liabilities
Deferred revenues
Senior Notes, Current
Total current liabilities
Long-term deferred revenues
Senior Notes
Long-term Senior Notes
Other long-term liabilities
Total long-term liabilities
Total liabilities
Stockholders' deficit:
Preferred stock-par value $.001 per share
Common Stocks, Including Additional Paid in Capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' deficit
Total liabilities and stockholders' deficit
Preferred stock, par value
Preferred stock, authorized shares
Common stock, par value
Common stock, authorized shares
Common Stock, Shares, Issued
Common stock, outstanding shares

Comments